ResearcherHirosaki UniversityNo recent work listed

Shinji Tsutsumi

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2011: 2 papers

Papers 2

L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/jso.21880 ↗
Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer. Co-author DOI 10.3892/ol.2011.412 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kenichi Hakamada · 2 shared papers, 2011 · strength 0.05
- Paper L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic du… DOI 10.1002/jso.21880 ↗
- Paper Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer. DOI 10.3892/ol.2011.412 ↗
Keinosuke Ishido · 2 shared papers, 2011 · strength 0.05
- Paper L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic du… DOI 10.1002/jso.21880 ↗
- Paper Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer. DOI 10.3892/ol.2011.412 ↗
Hiroshi Kijima · 1 shared paper, 2011 · strength 0.03
- Paper L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic du… DOI 10.1002/jso.21880 ↗
Daisuke Kudo · 1 shared paper, 2011 · strength 0.02
- Paper Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer. DOI 10.3892/ol.2011.412 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.